Large Cap Archives - Page 24 of 437

2 minute read

Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide

May 21, 9:36 AM

Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic. This move signals a significant expansion in the Asian market, where GLP-1 agonists are poised to drive a $2 billion market by 2030.

LLY

2 minute read

Goldman Sachs Raises Forecast For Chinese Market: Stock Ideas To Bet On Recovery Momentum

By Piero Cingari

May 21, 9:32 AM

Goldman Sachs sees potential for further rise in Chinese stocks due to improving macroeconomic performance and policy support, with a 60% probability of continuing gains and potential average returns of 35% in the next 6 months.

BABA

1 minute read

GSK’s Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows

By Vandana Singh

May 21, 8:31 AM

GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe asthma exacerbations.

GSK

1 minute read

ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development

By Vandana Singh

May 21, 8:24 AM

Sanofi collaborates with OpenAI and Formation Bio to enhance drug development. The partnership leverages proprietary data, advanced AI models, and engineering expertise to accelerate the biopharma lifecycle.

MRNA

2 minute read

AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion

By Vandana Singh

May 21, 7:16 AM

AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.

AZN

2 minute read

Pipeline Power Play: Phillips 66 Makes $550M Gas Grab In The Permian Basin

By Lekha Gupta

May 21, 6:49 AM

Phillips 66 to acquire Pinnacle Midstream for $550 million, expanding natural gas footprint in Midland Basin. CEO aims for operational synergy.

CRAK

2 minute read

AI-Driven Rally Set To Expand To Power, Commodities, Utilities: ‘It’s Not Just About Nvidia Anymore’

By Piero Cingari

May 20, 4:51 PM

Nvidia prepares for Q1 2024 earnings, with EPS expected to be 5x higher than last year and revenue projected to be 3x higher. AI-driven gains extend beyond chipmaking to power, commodities, and utilities, with Nvidia's market cap increasing by $1.5 trillion since Q1 2023.

CEG

2 minute read

Why Is Dyne Therapeutics Stock Soaring On Monday?

By Vandana Singh

May 20, 3:53 PM

Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne muscular dystrophy. Improvements in splicing correction, myotonia, muscle strength, and dystrophin expression were observed.

DYN

1 minute read

Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population

By Vandana Singh

May 20, 2:38 PM

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with higher blood eosinophil counts.

AMGN

2 minute read

Medtronic’s Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat

By Vandana Singh

May 20, 2:22 PM

Medtronic's SPHERE Per-AF study results reveal the Sphere-9 Catheter's superior safety and efficacy in treating persistent atrial fibrillation compared to the Thermocool SmartTouch SF. The Sphere-9 offers advanced mapping and ablation, showing higher freedom from AFib and fewer complications.

MDT